Skip to main content
logo
Generation Bio Co. (GBIO)
Feb 9, 2026 - GBIO was delisted (reason: acquired by XOMA)
5.34
-0.40 (-6.97%)
Inactive · Last trade price on Feb 6, 2026

Generation Bio Co. Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
15.2719.895.9---
Revenue Growth
-17.82%236.92%----
Gross Profit
15.2719.895.9---
Operating Income
-69.79-142.39-138.56-141.18-119.1-81.11
Net Income
-62.63-131.67-126.61-136.64-119.15-80.52
Earnings Per Share
-9.34-19.80-19.60-23.50-21.20-29.50
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
89.62185.22264.36279.09375.15262.33
Total Debt
26.193.5697.8981.7180.830
Net Cash (Debt)
63.5391.66166.47197.38294.32262.33
Net Cash Growth
-40.09%-44.94%-15.66%-32.94%12.20%1640.03%
Net Cash Per Share
9.4713.7625.8233.9652.2896.24

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-113.65-88.56-52.75-102.45-91.82-70.14
Capital Expenditures
--2.4-7.4-8.8-5.96-5.52
Free Cash Flow
-113.65-90.96-60.14-111.25-97.78-75.66
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
100.00%100.00%100.00%---
Operating Margin
-457.06%-715.82%-2346.93%---
Pretax Margin
-410.13%-661.91%-2144.51%---
Profit Margin
-410.13%-661.91%-2144.51%---
FCF Margin
-744.28%-457.29%-1018.67%---

Valuation
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingAug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
2.343.5718.50---